Don't mind the brand name Haloette in fact I think it is quite brilliant. Even though approval has been delayed the fact that it now can be detailed along side Nextellis will generate complimentary prescriber awareness. The benefit of a better shelf life is a positive and the need for longer term stability studies explains the delay in gaining approval. I also cannot believe that it has not been tagged as market sensitive. It is a valuable addition to the strategic portfolio of women's health specialty products.
Don't mind the brand name Haloette in fact I think it is quite...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.03 |
Change
-0.170(3.27%) |
Mkt cap ! $408.6M | |||
| Open | High | Low | Value | Volume |
| $5.20 | $5.21 | $5.03 | $2.804M | 555.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14654 | $5.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.14 | 3111 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |